Background The management of uncontrolled severe asthma has greatly improved since
the advent of novel biologic therapies. Up to August 2022, five biologics have been …

Background: Confidential enquiries into asthma deaths can identify inadequacies in medical
management and factors which contribute to patients' death. Aims: To identify risk factors for …

Asthma drugs are amongst the most frequently used drugs in childhood, but international
comparisons on type and indication of use are lacking. The aim of this study was to describe …

OBJECTIVE: The aim of this study was to identify risk factors for long-term adverse outcomes
in children with asthma after visiting the emergency department (ED). METHODS: A …

Background Safety concerns associated with long-acting β 2-agonists (LABAs) have led to
many US Food and Drug Administration (FDA) regulatory activities for this class of drugs …

Background Many factors affect use of inhaled therapy in asthma. Relatively little is known
about current patterns of use of anti-inflammatory medication in children with asthma and …

OBJECTIVE: In young children with asthmatic symptoms diagnostic difficulties lead to use of
trials of asthma medication as a diagnostic tool. Our aim is to quantify the persistent use of …

Objective We evaluated the adherence to national guidelines for the treatment of asthma in
childhood. Methods Prescriptions for anti-asthma medication for children (0–14 years of …

Abstract Purpose Stock et al.(Eur Respir J 25: 47–53, 2005) recently estimated asthma
prevalence in Germany using claims data on prescriptions and hospital diagnoses and …

Although progress has been made in understanding asthma, much remains unknown; as a
result, diagnosis and treatment are not optimal. Information is still needed about the natural …